Aspirin use among adults with diabetes: Estimates from the Third National Health and Nutrition Examination Survey

Diabetes Care

Volumn 24, Issue 2, 2001, Pages 197-201

  Rolka, Deborah B ^a,b   Fagot Campagna, Anne ^a   Narayan, K M Venkat ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b Mailstop K 68 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; FAMILY HISTORY; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEINURIA; RACE; SELF REPORT; SMOKING; TREATMENT OUTCOME;

EID: 0035140649     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.2.197     Document Type: Article

References (34)

1. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
2. Increased platelet thromboxane synthesis in diabetes mellitus
3. Thromboxane biosynthesis and platelet function in type II diabetes mellitus
4. Aspirin as an antiplatelet drug
5. Final report on the aspirin component of the ongoing Physicians' Health Study
6. Collaborative overview of randomized trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
7. Aspirin effects on mortality and morbidity in patients with diabetes mellitus
8. Aspirin therapy in diabetes
9. Aspirin therapy in diabetes (Position Statement)
10. Aspirin therapy in diabetes (Position Statement)
11. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994
12. Update on aspirin in the treatment and prevention of cardiovascular disease
13. Which diabetic patients should be taking aspirin? Those with vascular disease and those at greatly increased risk of vascular disease
14. Guidelines for medical treatment for stroke prevention
15. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
16. Impact of diabetes on mortality after the first myocardial infarction
17. Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease
18. Does professional advice influence aspirin use to prevent heart disease in an HMO population?
19. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
20. Patterns of aspirin use in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study
21. Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: Missed opportunities for prevention?
22. Aspirin use is low among United States outpatients with coronary artery disease
23. Underuse of cardiac procedures: Do women, ethnic minorities, and the uninsured fail to receive needed revascularization?
24. Use of cardiovascular procedures among black persons and white persons: A 7-year nationwide study in patients with renal disease
25. Use of aspirin for prevention of cardiovascular disease-1981-82 to 1985-86: The Minnesota Heart Survey
26. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: Evidence for undertreatment in women and the elderly
27. Improving the quality of care for Medicare patients with acute myocardial infarction: Results from the Cooperative Cardiovascular Project
28. Health plan employer data and information set (HEDIS 1999)
29. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: The Third National Health and Nutrition Examination Survey, 1988-1994